Permanently Discontinued

MYCOPHENOLATE MOFETIL FOR INJECTION USP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MYCOPHENOLATE MOFETIL FOR INJECTION USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MYCOPHENOLATE MOFETIL FOR INJECTION USP 500MG has been permanently discontinued (last updated August 7, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MYCOPHENOLATE MOFETIL FOR INJECTION USP not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 2 same form & route

Affected strength500MG

Report last updated2024-08-07

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CELLCEPT I.V.

HOFFMANN-LA ROCHE LIMITED

500MG · DIN 02240347

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MYCOPHENOLATE MOFETIL FOR INJECTION, USP

ACCORD HEALTHCARE INC

500MG · DIN 02444836

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

JAMP-MYCOPHENOLATE

JAMP PHARMA CORPORATION

500MG · DIN 02380382

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ACH-MYCOPHENOLATE

ACCORD HEALTHCARE INC

500MG · DIN 02378574

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

MYCOPHENOLATE MOFETIL

SANIS HEALTH INC

500MG · DIN 02457377

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CELLCEPT

HOFFMANN-LA ROCHE LIMITED

250MG · DIN 02192748

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02479974

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

MYCOPHENOLATE MOFETIL

See all MYCOPHENOLATE MOFETIL products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2024-08-07

Permanently Discontinued

Business reasons

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890